USDA-ARS Beltsville Human Nutrition Research Center
Beltsville, Maryland, 20705, United States
NCT Number: NCT04104581
The primary objective of this study is to identify markers of daily whole grain oat and whole grain wheat intake in humans.
Looking for future studies?
Notify Me21 year–75 year
All sexes
Interventional
Not applicable
Beltsville, Maryland, 20705, United States
The aim of this study is to identify compounds that are found in blood and urine and are derived from repeated daily consumption of whole grain oat or whole grain wheat intake so that epidemiological studies can be conducted to provide more accurate associations between whole grain intake and health.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be fed the average American diet except it will be free of whole grains
Subjects will be fed the average American diet with addition of a low level of whole grain oats
Subjects will be fed the average American diet with addition of a high level of whole grain oats
Subjects will be fed the average American diet with addition of a low level of whole grain wheat
Subjects will be fed the average American diet with addition of a high level of whole grain wheat
Time frame: Day 1 of Period 1 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 1 of Period 2 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 1 of Period 3 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 1 of Period 4 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 1 of Period 5 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 8 of Period 1 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 8 of Period 2 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 8 of Period 3 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 8 of Period 4 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 8 of Period 5 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 15 of Period 1 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 15 of Period 2 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 15 of Period 3 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 15 of Period 4 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 15 of Period 5 (period = 15 days)
Metabolomic analysis of blood samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 1, 8, and 15 of each of the 5 fifteen day diet periods
Metabolomic analysis of urine samples will be conducted; the selected intensity of biochemicals identified from liquid and gas chromatography with mass ranging from 50 to 800 molecular weight will be determined
Time frame: Day 1, 8, and 15 of each of the 5 fifteen day diet periods
Fecal samples will be analyzed for microbiota
Time frame: Day 1 and 15 of each of the 5 fifteen day diet periods
Fasting blood glucose will be measured in mg/dL
Time frame: Day 1 and 15 of each of the 5 fifteen day diet periods
Fasting blood insulin will be measured in uIU/mL
Time frame: Day 1 and 15 of each of the 5 fifteen day diet periods
Fasting blood triglycerides will be measured in mg/dL
Time frame: Day 1 and 15 of each of the 5 fifteen day diet periods
Fasting blood non esterified fatty acids will be measured in mEQ/L
USDA Beltsville Human Nutrition Research Center
Fed
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05447078
Healthy Volunteers, Infections
Jackson, Mississippi, United States
View Trial DetailsNCT07513532
Healthy Volunteers
Seattle, Washington, United States
View Trial DetailsNCT07090655
Healthy Volunteers
Brisbane, Australia
View Trial DetailsNCT01915212
Communicable Diseases, DNA Virus Infections
Bethesda, Maryland, United States
View Trial Details